Opportunities and Options for Treatment Research in Resource-Constrained Settings

Volberding, Paul A.
July 2003
Clinical Infectious Diseases;7/1/2003 Supplement 1, Vol. 37, pS1
Academic Journal
HIV clinical research faces limitations even in research-rich settings. Even though important questions remain unanswered, clinical trials will probably never be conducted that address, prospectively, when treatment is optimally indicated, for example. In resource-constrained settings, large, prospective clinical trials are also unlikely. On the other hand, ones with a more observational design or that compare cohort experiences may well be feasible and able to provide information important in those settings, as well as in regions with abundant financial resources.


Related Articles

  • Clinical Outcomes of Elite Controllers, Viremic Controllers, and Long-Term Nonprogressors in the US Department of Defense HIV Natural History Study. Okulicz, Jason F.; Marconi, Vincent C.; Landrum, Michael L.; Wegner, Scott; Weintrob, Amy; Ganesan, Anuradha; Hale, Braden; Crum-Cianflone, Nancy; Delmar, Judith; Barthel, Vincent; Quinnan, Gerald; Agan, Brian K.; Dolan, Matthew J. // Journal of Infectious Diseases;12/1/2009, Vol. 200 Issue 11, p1714 

    Durable control of human immunodeficiency virus (HIV) replication and lack of disease progression in the absence of antiretroviral therapy were studied in a military cohort of 4586 subjects. We examined groups of elite controllers (ie, subjects with plasma HIV RNA levels of <50 copies/mL;...

  • Primary HIV. Fox, J.; Weber, J.; Fidler, S. // Sexually Transmitted Infections;Aug2006, Vol. 82 Issue 4, p267 

    The author reflects on the importance of identifying the primary human immunodeficiency virus (HIV) infection to prevent the onward transmission of the virus during the hyper-infectious period. He states that there is no present confirmation to either support or refuse the prescription of...

  • Resisting Immune Exhaustion in HIV-1 Infection. Rowland-Jones, Sarah; de Silva, Thushan // PLoS Medicine;May2008, Vol. 5 Issue 5, pe103 

    Sarah Rowland-Jones and Thushan de Silva discuss a new study describing the fate of cytotoxic T lymphocytes responding to HIV-1 from very early through to chronic infection.

  • Human immunodeficiency virus type-1 episomal cDNA in semen. Chong Xu; Politch, Joseph A.; Mayer, Kenneth H.; Anderson, Deborah J. // AIDS Research & Therapy;2005, Vol. 2, p9 

    Background: Episomal 2-long terminal repeat (LTR) HIV-1 cDNA, a by-product of HIV-1 infection, is used in clinical trials as a marker for ongoing viral replication. It would be useful to employ 2-LTR cDNA to monitor cryptic HIV-1 infection in the genital tract of men on antiretroviral therapy...

  • No vaccine against HIV yet-are we not perfectly equipped? Singh, Mahender // Virology Journal;2006, Vol. 3, p1 

    Enormous effort has been devoted to the development of a vaccine against human immunodeficiency virus (HIV). But it is proving to be an unprecedented challenge to create an effective vaccine mainly due to the high genetic variability of the virus and the necessity of cytotoxic T lymphocytes...

  • Quality Control and Performance of HIV Rapid Tests in a Microbicide Clinical Trial in Rural KwaZulu-Natal. von Knorring, Nina; Gafos, Mitzy; Ramokonupi, Motsei; Jentsch, Ute // PLoS ONE;Jan2012, Vol. 7 Issue 1, p1 

    Background: Quality control (QC) and evaluation of HIV rapid test procedures are an important aspect of HIV prevention trials. We describe QC and performance of two rapid tests, Determineâ„¢ and Uni-Goldâ„¢ used in a microbicide clinical trial in rural KwaZulu-Natal, South Africa....

  • A HEALTHY DOSE OF information. Lynde, Michelle // Alive: Canada's Natural Health & Wellness Magazine;Dec2007, Issue 302, p46 

    The article describes the two categories of medical research, observational research and experimental research. Observational research includes a range of studies such as case-control studies and cohort studies. Experimental research on the other hand is generally conducted in phases, the...

  • Establishing a Cohort at High Risk of HIV Infection in South Africa: Challenges and Experiences of the CAPRISA 002 Acute Infection Study. van Loggerenberg, Francois; Mlisana, Koleka; Williamson, Carolyn; Auld, Sara C.; Morris, Lynn; Gray, Clive M.; Karim, Quarraisha Abdool; Grobler, Anneke; Barnabas, Nomampondo; Iriogbe, Itua; Karim, Salim S. Abdool // PLoS ONE;2008, Vol. 3 Issue 4, p1 

    Objectives: To describe the baseline demographic data, clinical characteristics and HIV-incidence rates of a cohort at high risk for HIV infection in South Africa as well as the challenges experienced in establishing and maintaining the cohort. Methodology/Principle Findings: Between August 2004...

  • Funding for HIV network extended.  // CMAJ: Canadian Medical Association Journal;06/01/97, Vol. 156 Issue 11, p1524 

    Reports on the extension of the federal government's stable funding for the Canadian HIV Trials Network (CTN). Research projects of the organization; National director of the group.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics